Biotechnology
Technology
Health

Aeterna Zentaris

$2.67
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.01 (0.40%) Today
+$0.13 (5.12%) As of 5:16 PM EDT after-hours

Why Robinhood?

You can buy or sell AEZS and other stocks, options, ETFs, and crypto commission-free!

About AEZS

Aeterna Zentaris Inc. Common Stock, also called Aeterna Zentaris, is engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health. Read More It operates through biopharmaceutical segment. AEterna Zentaris was founded on September 12, 1990 and is headquartered in Charleston, SC.

Employees
20
Headquarters
Charleston, South Carolina
Founded
1990
Market Cap
41.60M
Price-Earnings Ratio
β€”
Dividend Yield
0.00
Average Volume
70.10K
High Today
$2.60
Low Today
$2.35
Open Price
$2.53
Volume
131.00K
52 Week High
$5.57
52 Week Low
$1.29

Collections

Biotechnology
Technology
Health
Biopharmaceutical
Pharmaceutical
US
North America

AEZS Earnings

-$0.32
$0.08
$0.47
$0.87
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
β€”
Actual
Expected Aug 8, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.